Search
for
Sort by
Research 30 of 43
- Safety and efficacy of a topical treatment (SM04554) for androgenetic alopecia (AGA): Results from a phase 1 Trial
- Safety and biopsy outcomes of a topical treatment (SM04554) for male androgenetic alopecia (AGA): Results from a phase 2, multicenter, randomized, double-blind, vehicle-controlled trial
- 712 A small molecule modulator of the wnt pathway (SM04554) as a potential topical treatment for androgenetic alopecia (AGA)
- WNT Signaling in Disease
- New drugs under investigation for the treatment of alopecias
- Biotechs target stagnant baldness market
- Randomized controlled evaluator blinded study of dutasteride versus finasteride in men with androgenetic alopecia
- New Drugs for Alopecias
- Safety and efficacy of a novel skin lightening agent for melasma
- Safety and compatibility of a new nourishing baby shampoo and tip to toe wash with stearic acid
- Safety and efficacy of actinic keratoses reduction with a 3 day application of ingenol disoxate field treatment to the face, chest and balding scalp
- 710 Use of mass spectrometry imaging and a full thickness 3D skin equivalent for evaluation of percutaneous absorption
- Relapsing nail fibrokeratoma: A case report on a teenager
- Recent updates on Wnt signaling modulators: a patent review (2014-2020)
- Androgens and androgen receptor action in skin and hair follicles
- A review of the treatment of male pattern hair loss
- Novedades terapéuticas en tricología
- Androgenetic alopecia: combing the hair follicle signaling pathways for new therapeutic targets and more effective treatment options
- Experimental and early investigational drugs for androgenetic alopecia
- New Treatments for Hair Loss
- Clinical Trials and Hair Loss
- Alopesi Tedavisinde Kullanılan İlaç Tedavileri ve Yeni Yaklaşımlar
- 713 Fisetin promotes differentiation, inhibits proliferative and inflammatory responses in cultured human cells and alleviates psoriasiform dermatitis in mice
- 711 Small molecule wnt pathway inhibitor (SM04755) as a potential topical psoriasis treatment
- 708 SIG-1451: A topical anti-inflammatory new chemical entity for atopic dermatitis (AD)
- 709 Nitric oxide-releasing topical therapeutic agent for atopic dermatitis
- withdrawn
- Nouvelles thérapeutiques dans la prise en charge de l’alopécie androgénétique
- Wnt is back in drugmakers' sights, but is it druggable?
- Tectoridin Stimulates the Activity of Human Dermal Papilla Cells and Promotes Hair Shaft Elongation in Mouse Vibrissae Hair Follicle Culture